Tailor-made temporary organs for transplant emergencies are being tested in human patients — livers, arteries, and soon ...

Terumo's $1.5B OrganOx acquisition boosts organ preservation focus, leveraging advanced Metra tech for growth.

Terumo Corporation is acquiring OrganOx Limited to enhance organ preservation technology and address transplant challenges globally. Acquisition marks Terumo entry into transplant sector.

An agreement has been reached for an Oxford University spinout to be bought for $1.5 billion. OrganOx, which specialises in advanced technology for kidney and liver transplantation, is set to be ...

An agreement has been reached for an Oxford University spinout to be bought for $1.5 billion. OrganOx, which specialises in ...

Oxford University spin-out OrganOx has been acquired by global MedTech firm Terumo Corporation in a $1.5bn (£1.2bn) deal.

Terumo acquires Oxford spin-out OrganOx for $1.5bn, expanding global access to transplant organ preservation devices.

Japan-based global company Terumo Corporation has agreed to buy Oxford business OrganOx in a deal worth around $1.5 billion.

Every day, more than 100,000 Americans wait for an organ transplant that could save their lives. Despite over a decade of reaching record donor and transplant numbers in the U.S.

OrganOx could capture a greater share of the liver transplant market, where it competes with TransMedics Group, Needham ...

After raising more than $142 million in venture capital earlier this year to support its liver transplant technology, OrganOx ...

Terumo announced today that it entered into a definitive agreement to acquire OrganOx and its organ preservation technology.